EAACI Congress 2023

Back
09 - 11 June 2023 Hamburg, Germany

Efficacy and Safety of Oral Administered Bradykinin B2 Receptor Inhibitor PHVS416 in Treatment of Hereditary Angioedema Attacks: Topline Results of RAPIDe-1 Phase 2 Trial

Sunday 11 Jun, 14:42 PM - 14:49 PM CEST
Hall Y 11+12 Flash Talks

Chairs